The role of blood-brain barrier transporters in pathophysiology and pharmacotherapy of stroke

Current Pharmaceutical Design

Volumn 20, Issue 10, 2014, Pages 1510-1522

  Shah, Kaushik ^a   Abbruscato, Thomas ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Blood brain barrier; Edema; Glucose; Insulin; NCX; Neurovascular unit; NHE; NKCC; Phlorizin; SGLT; Stroke

Indexed keywords

GLUCOSE; GLUCOSE TRANSPORTER; ION;

BLOOD BRAIN BARRIER; BRAIN EDEMA; BRAIN INJURY; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; HOMEOSTASIS; HUMAN; ION TRANSPORT; MOLECULAR MECHANICS; NONHUMAN; NUTRIENT; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

ANIMALS; BLOOD-BRAIN BARRIER; DRUG DELIVERY SYSTEMS; HUMANS; MEMBRANE TRANSPORT PROTEINS; PHARMACEUTICAL PREPARATIONS; STROKE;

EID: 84897472698     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/13816128113199990465     Document Type: Review

References (238)

1. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation 2012; 125: e2-e220.
2. Dirnagl U, Iadecola C, Moskowitz MA. Pathobiology of ischaemic stroke: an integrated view. Trends in neurosciences 1999; 22: 391-7.
3. Lipton P. Ischemic cell death in brain neurons. Physiol Rev 1999; 79: 1431-568.
4. Davis SM, Lees KR, Albers GW, et al. Selfotel in acute ischemic stroke: possible neurotoxic effects of an NMDA antagonist. Stroke 2000; 31: 347-54.
5. Lees KR, Zivin JA, Ashwood T, et al. Stroke-Acute Ischemic NXYTTI. NXY-059 for acute ischemic stroke. N Engl J Med 2006; 354: 588-600.
6. Del Zoppo GJ, Saver JL, Jauch EC, Adams HP, Jr., American Heart Association Stroke C. Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association. Stroke 2009; 40: 2945-8.
7. Messe SR, Fonarow GC, Smith EE, et al. Use of tissue-type plasminogen activator before and after publication of the European Cooperative Acute Stroke Study III in Get With The Guidelines-Stroke. Circ Cardiovasc Qual Outcomes 2012; 5: 321-6.
8. Espinoza-Rojo M, Iturralde-Rodriguez KI, Chanez-Cardenas ME, Ruiz-Tachiquin ME, Aguilera P. Glucose transporters regulation on ischemic brain: possible role as therapeutic target. Central Nerv SysAgents Med Chem 2010; 10: 317-25.
9. Vannucci SJ, Seaman LB, Vannucci RC. Effects of hypoxiaischemia on GLUT1 and GLUT3 glucose transporters in immature rat brain. J Cereb Blood Flow Metab 1996; 16: 77-81.
10. Yeh WL, Lin CJ, Fu WM. Enhancement of glucose transporter expression of brain endothelial cells by vascular endothelial growth factor derived from glioma exposed to hypoxia. Mol Pharmacol 2008; 73: 170-7.
11. Rutkowsky JM, Wallace BK, Wise PM, O'Donnell ME. Effects of estradiol on ischemic factor-induced astrocyte swelling and AQP4 protein abundance. Am J Physiol Cell Physiol 2011; 301: C204-12.
12. Abbruscato TJ, Lopez SP, Roder K, Paulson JR. Regulation of blood-brain barrier Na, K, 2Cl-cotransporter through phosphorylation during in vitro stroke conditions and nicotine exposure. J Pharmacol Exp Therapeut 2004; 310: 459-68.
13. Kimelberg HK. Astrocytic swelling in cerebral ischemia as a possible cause of injury and target for therapy. Glia 2005; 50: 389-97.
14. Jayakumar AR, Norenberg MD. The Na-K-Cl Co-transporter in astrocyte swelling. Metabolic brain disease 2010; 25: 31-8.
15. Yang L, Shah K, Wang H, Karamyan VT, Abbruscato TJ. Characterization of neuroprotective effects of biphalin, an opioid receptor agonist, in a model of focal brain ischemia. J Pharmacol Exp Ther 2011; 339: 499-508.
16. Durukan A, Tatlisumak T. Acute ischemic stroke: overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia. Pharmacol Biochem Behav 2007; 87: 179-97.
17. Hosoya KI, Takashima T, Tetsuka K, et al. mRna expression and transport characterization of conditionally immortalized rat brain capillary endothelial cell lines; a new in vitro BBB model for drug targeting. J Drug Target 2000; 8: 357-70.
18. Ito K, Uchida Y, Ohtsuki S, et al. Quantitative membrane protein expression at the blood-brain barrier of adult and younger cynomolgus monkeys. J Pharm Sci 2011; 100: 3939-50.
19. Shawahna R, Uchida Y, Decleves X, et al. Transcriptomic and quantitative proteomic analysis of transporters and drug metabolizing enzymes in freshly isolated human brain microvessels. Mol Pharm 2011; 8: 1332-41.
20. Uchida Y, Ohtsuki S, Katsukura Y, et al. Quantitative targeted absolute proteomics of human blood-brain barrier transporters and receptors. J Neurochem 2011; 117: 333-45.
21. Umeki N, Fukasawa Y, Ohtsuki S, et al. mRNA expression and amino acid transport characteristics of cultured human brain microvascular endothelial cells (hBME). Drug Metab Pharmacokinet 2002; 17: 367-73.
22. Daneman R, Zhou L, Agalliu D, Cahoy JD, Kaushal A, Barres BA. The mouse blood-brain barrier transcriptome: a new resource for understanding the development and function of brain endothelial cells. PLoS One 2010; 5: e13741.
23. Gabathuler R. Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases. Neurobiol Dis 2010; 37: 48-57.
24. Vorbrodt AW. Ultrastructural cytochemistry of blood-brain barrier endothelia. Prog Histochem Cytochem 1988; 18: 1-99.
25. Guo X, Geng M, Du G. Glucose transporter 1, distribution in the brain and in neural disorders: its relationship with transport of neuroactive drugs through the blood-brain barrier. Biochem Genet 2005; 43: 175-87.
26. Pardridge WM, Boado RJ, Farrell CR. Brain-type glucose transporter (GLUT-1) is selectively localized to the blood-brain barrier. Studies with quantitative western blotting and in situ hybridization. The J biological chemistry 1990; 265: 18035-40.
27. Dwyer KJ, Pardridge WM. Developmental modulation of bloodbrain barrier and choroid plexus GLUT1 glucose transporter messenger ribonucleic acid and immunoreactive protein in rabbits. Endocrinology 1993; 132: 558-65.
28. Betz AL, Gilboe DD, Drewes LR. Effects of anoxia on net uptake and unidirectional transport of glucose into the isolated dog brain. Brain Res 1974; 67: 307-16.
29. Watson BD, Prado R, Veloso A, Brunschwig JP, Dietrich WD. Cerebral blood flow restoration and reperfusion injury after ultraviolet laser-facilitated middle cerebral artery recanalization in rat thrombotic stroke. Stroke 2002; 33: 428-34.
30. Aronowski J, Strong R, Grotta JC. Reperfusion injury: demonstration of brain damage produced by reperfusion after transient focal ischemia in rats. J Cereb Blood Flow Metab 1997; 17: 1048-56.
31. Maher F, Vannucci SJ, Simpson IA. Glucose transporter proteins in brain. FASEB J 1994; 8: 1003-11.
32. Devaskar SU, Rajakumar PA, Mink RB, McKnight RA, Thamotharan S, Hicks SJ. Effect of development and hypoxicischemia upon rabbit brain glucose transporter expression. Brain research 1999; 823: 113-28.
33. de Courten-Myers G, Myers RE, Schoolfield L. Hyperglycemia enlarges infarct size in cerebrovascular occlusion in cats. Stroke 1988; 19: 623-30.
34. de Courten-Myers GM, Myers RE, Wagner KR. Effect of hyperglycemia on infarct size after cerebrovascular occlusion in cats. Stroke 1990; 21: 357-8.
35. Schurr A, Payne RS, Tseng MT, Miller JJ, Rigor BM. The glucose paradox in cerebral ischemia. New insights. Ann N Y Acad Sci 1999; 893: 386-90.
36. Myers RE, Yamaguchi S. Nervous system effects of cardiac arrest in monkeys. Preservation of vision. Arch Neurol 1977; 34: 65-74.
37. Liu Y, Mituska S, Hashizume K, Hosaka T, Nukui H. The time course of glucose metabolism in rat cerebral ischemia with middle cerebral artery occlusion-reperfusion model and the effect of MK-801. Neurol Res 1996; 18: 505-8.
38. Liu Y, Mituska S, Hashizume K, Hosaka T, Nukui H. The sequential change of local cerebral blood flow and local cerebral glucose metabolism after focal cerebral ischaemia and reperfusion in rat and the effect of MK-801 on local cerebral glucose metabolism. Acta Neurochir (Wien) 1997; 139: 770-9.
39. Pulsinelli WA, Levy DE, Duffy TE. Regional cerebral blood flow and glucose metabolism following transient forebrain ischemia. Ann Neurol 1982; 11: 499-502.
40. Abate MG, Trivedi M, Fryer TD, et al. Early derangements in oxygen and glucose metabolism following head injury: the ischemic penumbra and pathophysiological heterogeneity. Neurocrit Care 2008; 9: 319-25.
41. Wei J, Cohen DM, Quast MJ. Effects of 2-deoxy-d-glucose on focal cerebral ischemia in hyperglycemic rats. J Cereb Blood Flow Metab 2003; 23: 556-64.
42. Yu ZF, Mattson MP. Dietary restriction and 2-deoxyglucose administration reduce focal ischemic brain damage and improve behavioral outcome: evidence for a preconditioning mechanism. J Neurosci Res 1999; 57: 830-9.
43. Niwa M, Hara A, Iwai T, et al. Prevention of ischemia-induced hippocampal neuronal damage by 2-deoxy-D-glucose in gerbils. Life Sci 1999; 64: PL193-8.
44. Zhang WW, Zhang L, Hou WK, et al. Dynamic expression of glucose transporters 1 and 3 in the brain of diabetic rats with cerebral ischemia reperfusion. Chin Med J (Engl) 2009; 122: 1996-2001.
45. Gerhart DZ, Leino RL, Taylor WE, Borson ND, Drewes LR. GLUT1 and GLUT3 gene expression in gerbil brain following brief ischemia: an in situ hybridization study. Brain Res Mol Brain Res 1994; 25: 313-22.
46. Vemula S, Roder KE, Yang T, Bhat GJ, Thekkumkara TJ, Abbruscato TJ. A functional role for sodium-dependent glucose transport across the blood-brain barrier during oxygen glucose deprivation. J Pharmacol Exp Ther 2009; 328: 487-95.
47. Urabe T, Hattori N, Nagamatsu S, Sawa H, Mizuno Y. Expression of glucose transporters in rat brain following transient focal ischemic injury. J Neurochem 1996; 67: 265-71.
48. Scott JF, Robinson GM, French JM, O'Connell JE, Alberti KG, Gray CS. Glucose potassium insulin infusions in the treatment of acute stroke patients with mild to moderate hyperglycemia: the Glucose Insulin in Stroke Trial (GIST). Stroke 1999; 30: 793-9.
49. Li PA, Shuaib A, Miyashita H, He QP, Siesjo BK, Warner DS. Hyperglycemia enhances extracellular glutamate accumulation in rats subjected to forebrain ischemia. Stroke 2000; 31: 183-92.
50. Swanson RA, Chen J, Graham SH. Glucose can fuel glutamate uptake in ischemic brain. J Cereb Blood Flow Metab 1994; 14: 1-6.
51. Li PA, Siesjo BK. Role of hyperglycaemia-related acidosis in ischaemic brain damage. Acta Physiol Scand 1997; 161: 567-80.
52. Kahles T, Luedike P, Endres M, et al. NADPH oxidase plays a central role in blood-brain barrier damage in experimental stroke. Stroke 2007; 38: 3000-6.
53. Suh SW, Shin BS, Ma H, et al. Glucose and NADPH oxidase drive neuronal superoxide formation in stroke. Ann Neurol 2008; 64: 654-63.
54. Lindsberg PJ, Roine RO. Hyperglycemia in acute stroke. Stroke 2004; 35: 363-4.
55. Parsons MW, Barber PA, Desmond PM, et al. Acute hyperglycemia adversely affects stroke outcome: a magnetic resonance imaging and spectroscopy study. Ann Neurol 2002; 52: 20-8.
56. Park WS, Chang YS, Lee M. Effects of hyperglycemia or hypoglycemia on brain cell membrane function and energy metabolism during the immediate reoxygenation-reperfusion period after acute transient global hypoxia-ischemia in the newborn piglet. Brain Res 2001; 901: 102-8.
57. D'Alecy LG, Lundy EF, Barton KJ, Zelenock GB. Dextrose containing intravenous fluid impairs outcome and increases death after eight minutes of cardiac arrest and resuscitation in dogs. Surgery 1986; 100: 505-11.
58. Venables GS, Miller SA, Gibson G, Hardy JA, Strong AJ. The effects of hyperglycaemia on changes during reperfusion following focal cerebral ischaemia in the cat. J Neurol Neurosurg Psychiatry 1985; 48: 663-9.
59. Bruckner BA, Ammini CV, Otal MP, Raizada MK, Stacpoole PW. Regulation of brain glucose transporters by glucose and oxygen deprivation. Metabolism: clinical and experimental 1999; 48: 422-31.
60. Fuentes B, Castillo J, San Jose B, et al. Stroke Project of the Cerebrovascular Diseases Study Group SSoN. The prognostic value of capillary glucose levels in acute stroke: the GLycemia in Acute Stroke (GLIAS) study. Stroke 2009; 40: 562-8.
61. Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 2001; 32: 2426-32.
62. Yong M, Kaste M. Dynamic of hyperglycemia as a predictor of stroke outcome in the ECASS-II trial. Stroke 2008; 39: 2749-55.
63. Gray CS, Hildreth AJ, Sandercock PA, et al. Glucose-potassiuminsulin infusions in the management of post-stroke hyperglycaemia: the UK Glucose Insulin in Stroke Trial (GISTUK). Lancet Neurol 2007; 6: 397-406.
64. Allport L, Baird T, Butcher K, et al. Frequency and temporal profile of poststroke hyperglycemia using continuous glucose monitoring. Diabetes Care 2006; 29: 1839-44.
65. Baird TA, Parsons MW, Barber PA, et al. The influence of diabetes mellitus and hyperglycaemia on stroke incidence and outcome. J Clin Neurosci 2002; 9: 618-26.
66. Baird TA, Parsons MW, Phanh T, et al. Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome. Stroke 2003; 34: 2208-14.
67. Wagner KR, Kleinholz M, de Courten-Myers GM, Myers RE. Hyperglycemic versus normoglycemic stroke: topography of brain metabolites, intracellular pH, and infarct size. J Cereb Blood Flow Metab 1992; 12: 213-22.
68. De Silva DA, Ebinger M, Christensen S, et al. Echoplanar Imaging Thrombolytic Evaluation Trial I. Baseline diabetic status and admission blood glucose were poor prognostic factors in the EPITHET trial. Cerebrovasc Dis 2010; 29: 14-21.
69. Kruyt ND, Biessels GJ, Devries JH, Roos YB. Hyperglycemia in acute ischemic stroke: pathophysiology and clinical management. Nat Rev Neurol 2010; 6: 145-55.
70. Rosso C, Corvol JC, Pires C, et al. Intensive Versus Subcutaneous Insulin in Patients With Hyperacute Stroke: Results From the Randomized INSULINFARCT Trial. Stroke 2012.
71. Investigators N-SS, Finfer S, Chittock DR, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009; 360: 1283-97.
72. Johnston KC, Hall CE, Kissela BM, Bleck TP, Conaway MR, Investigators G. Glucose Regulation in Acute Stroke Patients (GRASP) trial: a randomized pilot trial. Stroke 2009; 40: 3804-9.
73. Bruno A, Kent TA, Coull BM, et al. Treatment of hyperglycemia in ischemic stroke (THIS): a randomized pilot trial. Stroke 2008; 39: 384-9.
74. Hamilton MG, Tranmer BI, Auer RN. Insulin reduction of cerebral infarction due to transient focal ischemia. J Neurosurg 1995; 82: 262-8.
75. Kreisel SH, Berschin UM, Hammes HP, et al. Pragmatic management of hyperglycaemia in acute ischaemic stroke: safety and feasibility of intensive intravenous insulin treatment. Cerebrovasc Dis 2009; 27: 167-75.
76. McCormick M, Hadley D, McLean JR, Macfarlane JA, Condon B, Muir KW. Randomized, controlled trial of insulin for acute poststroke hyperglycemia. Ann Neurol 2010; 67: 570-8.
77. Staszewski J, Brodacki B, Kotowicz J, Stepien A. Intravenous insulin therapy in the maintenance of strict glycemic control in nondiabetic acute stroke patients with mild hyperglycemia. J Stroke Cerebrovasc Dis 2011; 20: 150-4.
78. Walters MR, Weir CJ, Lees KR. A randomised, controlled pilot study to investigate the potential benefit of intervention with insulin in hyperglycaemic acute ischaemic stroke patients. Cerebrovasc Dis 2006; 22: 116-22.
79. Bellolio MF, Gilmore RM, Stead LG. Insulin for glycaemic control in acute ischaemic stroke. Cochrane Database Syst Rev 2011: CD005346.
80. de Courten-Myers GM, Kleinholz M, Wagner KR, Myers RE. Normoglycemia (not hypoglycemia) optimizes outcome from middle cerebral artery occlusion. J Cereb Blood Flow Metab 1994; 14: 227-36.
81. Zhu CZ, Auer RN. Optimal blood glucose levels while using insulin to minimize the size of infarction in focal cerebral ischemia. J Neurosurg 2004; 101: 664-8.
82. Liu Y, Cao Y, Zhang W, et al. A Small-Molecule Inhibitor of Glucose Transporter 1 Downregulates Glycolysis, Induces Cell-Cycle Arrest, and Inhibits Cancer Cell Growth In vitro and In vivo. Mol Cancer Ther 2012.
83. Zhang EY, Knipp GT, Ekins S, Swaan PW. Structural biology and function of solute transporters: implications for identifying and designing substrates. Drug Metab Rev 2002; 34: 709-50.
84. Zeuthen T, Belhage B, Zeuthen E. Water transport by Na+-coupled cotransporters of glucose (SGLT1) and of iodide (NIS). The dependence of substrate size studied at high resolution. J Physiol 2006; 570: 485-99.
85. Zeuthen T, Zeuthen E, Klaerke DA. Mobility of ions, sugar, and water in the cytoplasm of Xenopus oocytes expressing Na(+)-coupled sugar transporters (SGLT1). J Physiol 2002; 542: 71-87.
86. Zeuthen T, Meinild AK, Loo DD, Wright EM, Klaerke DA. Isotonic transport by the Na+-glucose cotransporter SGLT1 from humans and rabbit. J Physiol 2001; 531: 631-44.
87. Loo DD, Hirayama BA, Meinild AK, Chandy G, Zeuthen T, Wright EM. Passive water and ion transport by cotransporters. J Physiol 1999; 518 (Pt 1): 195-202.
88. Eskandari S, Wright EM, Loo DD. Kinetics of the reverse mode of the Na+/glucose cotransporter. J Membr Biol 2005; 204: 23-32.
89. Yu AS, Hirayama BA, Timbol G, et al. Functional expression of SGLTs in rat brain. Am J Physiol Cell Physiol 2010; 299: C1277-84.
90. Gerhart DZ, Broderius MA, Borson ND, Drewes LR. Neurons and microvessels express the brain glucose transporter protein GLUT3. Proc Natl Acad Sci U S A 1992; 89: 733-7.
91. Enerson BE, Drewes LR. The rat blood-brain barrier transcriptome. J Cereb Blood Flow Metab 2006; 26: 959-73.
92. Nishizaki T, Kammesheidt A, Sumikawa K, Asada T, Okada Y. A sodium-and energy-dependent glucose transporter with similarities to SGLT1-2 is expressed in bovine cortical vessels. Neurosci Res 1995; 22: 13-22.
93. Matsuoka T, Nishizaki T, Kisby GE. Na+-dependent and phlorizininhibitable transport of glucose and cycasin in brain endothelial cells. J Neurochem 1998; 70: 772-7.
94. Elfeber K, Kohler A, Lutzenburg M, et al. Localization of the Na+-D-glucose cotransporter SGLT1 in the blood-brain barrier. Histochem Cell Biol 2004; 121: 201-7.
95. Balen D, Ljubojevic M, Breljak D, et al. Revised immunolocalization of the Na+-D-glucose cotransporter SGLT1 in rat organs with an improved antibody. Am J Physiol Cell Physiol 2008; 295: C475-89.
96. Poppe R, Karbach U, Gambaryan S, et al. Expression of the Na+-D-glucose cotransporter SGLT1 in neurons. J Neurochem 1997; 69: 84-94.
97. Rosenstock J, Vico M, Wei L, Salsali A, List JF. Effects of Dapagliflozin, an SGLT2 Inhibitor, on HbA1c, Body Weight, and Hypoglycemia Risk in Patients With Type 2 Diabetes Inadequately Controlled on Pioglitazone Monotherapy. Diabetes Care 2012; 35: 1473-8.
98. Lee SH, Song KS, Kim JY, et al. Novel thiophenyl C-aryl glucoside SGLT2 inhibitors as potential antidiabetic agents. Bioorg Med Chem 2011; 19: 5813-32.
99. Kang SY, Kim MJ, Lee JS, Lee J. Glucosides with cyclic diarylpolynoid as novel C-aryl glucoside SGLT2 inhibitors. Bioorg Med Chem Lett 2011; 21: 3759-63.
100. Chao EC. A paradigm shift in diabetes therapy--dapagliflozin and other SGLT2 inhibitors. Discov Med 2011; 11: 255-63.
101. Li AR, Zhang J, Greenberg J, Lee T, Liu J. Discovery of nonglucoside SGLT2 inhibitors. Bioorg Med Chem Lett 2011; 21: 2472-5.
102. Meng W, Ellsworth BA, Nirschl AA, et al. Discovery of dapagliflozin: a potent, selective renal sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes. J Med Chem 2008; 51: 1145-9.
103. Harik SI, Behmand RA, LaManna JC. Hypoxia increases glucose transport at blood-brain barrier in rats. J Appl Physiol 1994; 77: 896-901.
104. Zovein A, Flowers-Ziegler J, Thamotharan S, et al. Postnatal hypoxic-ischemic brain injury alters mechanisms mediating neuronal glucose transport. Am J Physiol Regul Integr Comp Physiol 2004; 286: R273-82.
105. Vannucci SJ, Reinhart R, Maher F, et al. Alterations in GLUT1 and GLUT3 glucose transporter gene expression following unilateral hypoxia-ischemia in the immature rat brain. Brain Res Dev Brain Res 1998; 107: 255-64.
106. Lee WH, Bondy CA. Ischemic injury induces brain glucose transporter gene expression. Endocrinology 1993; 133: 2540-4.
107. McCall AL, Van Bueren AM, Nipper V, Moholt-Siebert M, Downes H, Lessov N. Forebrain ischemia increases GLUT1 protein in brain microvessels and parenchyma. J Cereb Blood Flow Metab 1996; 16: 69-76.
108. Blomqvist G, Gjedde A, Gutniak M, et al. Facilitated transport of glucose from blood to brain in man and the effect of moderate hypoglycaemia on cerebral glucose utilization. Eur J Nucl Med 1991; 18: 834-7.
109. Mastaitis JW, Wurmbach E, Cheng H, Sealfon SC, Mobbs CV. Acute induction of gene expression in brain and liver by insulininduced hypoglycemia. Diabetes 2005; 54: 952-8.
110. Boado RJ, Pardridge WM. Glucose deprivation causes posttranscriptional enhancement of brain capillary endothelial glucose transporter gene expression via GLUT1 mRNA stabilization. J neurochemistry 1993; 60: 2290-6.
111. Nagamatsu S, Sawa H, Inoue N, Nakamichi Y, Takeshima H, Hoshino T. Gene expression of GLUT3 glucose transporter regulated by glucose in vivo in mouse brain and in vitro in neuronal cell cultures from rat embryos. Biochem J 1994; 300 (Pt 1): 125-31.
112. Uehara Y, Nipper V, McCall AL. Chronic insulin hypoglycemia induces GLUT-3 protein in rat brain neurons. Am J Physiol 1997; 272: E716-9.
113. Duelli R, Staudt R, Duembgen L, Kuschinsky W. Increase in glucose transporter densities of Glut3 and decrease of glucose utilization in rat brain after one week of hypoglycemia. Brain Res 1999; 831: 254-62.
114. Koranyi L, Bourey RE, James D, Mueckler M, Fiedorek FT, Jr., Permutt MA. Glucose transporter gene expression in rat brain: Pretranslational changes associated with chronic insulin-induced hypoglycemia, fasting, and diabetes. Mol Cell Neurosci 1991; 2: 244-52.
115. Kumagai AK, Kang YS, Boado RJ, Pardridge WM. Upregulation of blood-brain barrier GLUT1 glucose transporter protein and mRNA in experimental chronic hypoglycemia. Diabetes 1995; 44: 1399-404.
116. McCall AL, Fixman LB, Fleming N, Tornheim K, Chick W, Ruderman NB. Chronic hypoglycemia increases brain glucose transport. Am J Physiol 1986; 251: E442-7.
117. Pelligrino DA, Segil LJ, Albrecht RF. Brain glucose utilization and transport and cortical function in chronic vs. acute hypoglycemia. Am J Physiol 1990; 259: E729-35.
118. Betz AL, Gilboe DD, Yudilevich DL, Drewes LR. Kinetics of unidirectional glucose transport into the isolated dog brain. Am J Physiol 1973; 225: 586-92.
119. Betz AL, Iannotti F, Hoff JT. Ischemia reduces blood-to-brain glucose transport in the gerbil. J Cereb Blood Flow Metab 1983; 3: 200-6.
120. Choki J, Greenberg J, Reivich M. Regional cerebral glucose metabolism during and after bilateral cerebral ischemia in the gerbil. Stroke 1983; 14: 568-74.
121. Kintner D, Costello DJ, Levin AB, Gilboe DD. Brain metabolism after 30 minutes of hypoxic or anoxic perfusion or ischemia. Am J Physiol 1980; 239: E501-9.
122. Suzuki H, Nagashima T, Tamaki N, Yamadori T. Cerebral ischemia affects glucose transporter kinetics across rat brain microvascular endothelium: quantitative analysis by an in situ brain perfusion method. Surg Neurol 1998; 49: 67-76.
123. Yanushka JM, Costello DJ, Gilboe DD. Effect of blood pH and ischemia on kinetic constants for cerebral glucose transport. Am J Physiol 1983; 245: E384-90.
124. Vyska K, Magloire JR, Freundlieb C, et al. In vivo determination of the kinetic parameters of glucose transport in the human brain using 11C-methyl-D-glucose (CMG) and dynamic positron emission tomography (dPET). Eur J Nucl Med 1985; 11: 97-106.
125. Wu F, Wu J, Nicholson AD, et al. Tissue-Type Plasminogen Activator Regulates the Neuronal Uptake of Glucose in the Ischemic Brain. J Neurosci 2012; 32: 9848-9858.
126. Keep RF, Xiang J, Betz AL. Potassium transport at the blood-brain and blood-CSF barriers. Adv Exp Med Biol 1993; 331: 43-54.
127. Cserr HF, Depasquale M, Patlak CS, Pullen RG. Convection of cerebral interstitial fluid and its role in brain volume regulation. Ann N Y Acad Sci 1986; 481: 123-34.
128. Redzic ZB, Segal MB. The structure of the choroid plexus and the physiology of the choroid plexus epithelium. Adv Drug Deliv Rev 2004; 56: 1695-716.
129. Abbott NJ. Evidence for bulk flow of brain interstitial fluid: significance for physiology and pathology. Neurochem Int 2004; 45: 545-52.
130. Hata R, Maeda K, Hermann D, Mies G, Hossmann KA. Evolution of brain infarction after transient focal cerebral ischemia in mice. J Cereb Blood Flow Metab 2000; 20: 937-46.
131. Hata R, Maeda K, Hermann D, Mies G, Hossmann KA. Dynamics of regional brain metabolism and gene expression after middle cerebral artery occlusion in mice. J Cereb Blood Flow Metab 2000; 20: 306-15.
132. Mintorovitch J, Yang GY, Shimizu H, Kucharczyk J, Chan PH, Weinstein PR. Diffusion-weighted magnetic resonance imaging of acute focal cerebral ischemia: comparison of signal intensity with changes in brain water and Na+, K(+)-ATPase activity. J Cereb Blood Flow Metab 1994; 14: 332-6.
133. Yang GY, Chen SF, Kinouchi H, Chan PH, Weinstein PR. Edema, cation content, and ATPase activity after middle cerebral artery occlusion in rats. Stroke 1992; 23: 1331-6.
134. Liu Y, Liu XJ, Sun D. Ion transporters and ischemic mitochondrial dysfunction. Cell Adh Migr 2009; 3: 94-8.
135. Walcott BP, Kahle KT, Simard JM. Novel treatment targets for cerebral edema. Neurotherapeutics 2012; 9: 65-72.
136. Simard JM, Kent TA, Chen M, Tarasov KV, Gerzanich V. Brain oedema in focal ischaemia: molecular pathophysiology and theoretical implications. Lancet Neurol 2007; 6: 258-68.
137. Foroutan S, Brillault J, Forbush B, O'Donnell ME. Moderate-tosevere ischemic conditions increase activity and phosphorylation of the cerebral microvascular endothelial cell Na+-K+-Clcotransporter. Am J Physiol Cell Physiol 2005; 289: C1492-501.
138. O'Donnell ME, Duong V, Suvatne J, Foroutan S, Johnson DM. Arginine vasopressin stimulation of cerebral microvascular endothelial cell Na-K-Cl cotransporter activity is V1 receptor and [Ca] dependent. Am J Physiol Cell Physiol 2005; 289: C283-92.
139. Betz AL. Sodium transport in capillaries isolated from rat brain. J Neurochem 1983; 41: 1150-7.
140. Yang T, Roder KE, Bhat GJ, Thekkumkara TJ, Abbruscato TJ. Protein kinase C family members as a target for regulation of blood-brain barrier Na, K, 2Cl-cotransporter during in vitro stroke conditions and nicotine exposure. Pharm Res 2006; 23: 291-302.
141. Brillault J, Lam TI, Rutkowsky JM, Foroutan S, O'Donnell ME. Hypoxia effects on cell volume and ion uptake of cerebral microvascular endothelial cells. Am J Physiol Cell Physiol 2008; 294: C88-96.
142. Kawai N, McCarron RM, Spatz M. Na(+)-K(+)-Cl-cotransport system in brain capillary endothelial cells: response to endothelin and hypoxia. Neurochem Res 1996; 21: 1259-66.
143. Kawai N, McCarron RM, Spatz M. The effect of endothelins on ion transport systems in cultured rat brain capillary endothelial cells. Acta Neurochir Suppl 1997; 70: 138-40.
144. Betz AL. Alterations in cerebral endothelial cell function in ischemia. Adv Neurol 1996; 71: 301-11; discussion 311-3.
145. Vibbert M, Mayer SA. Early decompressive hemicraniectomy following malignant ischemic stroke: the crucial role of timing. Curr Neurol Neurosci Rep 2010; 10: 1-3.
146. Belayev L, Busto R, Zhao W, Ginsberg MD. Quantitative evaluation of blood-brain barrier permeability following middle cerebral artery occlusion in rats. Brain Res 1996; 739: 88-96.
147. Kuroiwa T, Ting P, Martinez H, Klatzo I. The biphasic opening of the blood-brain barrier to proteins following temporary middle cerebral artery occlusion. Acta Neuropathol 1985; 68: 122-9.
148. Huang ZG, Xue D, Preston E, Karbalai H, Buchan AM. Biphasic opening of the blood-brain barrier following transient focal ischemia: effects of hypothermia. Can J Neurol Sci 1999; 26: 298-304.
149. Rosenberg GA, Estrada EY, Dencoff JE. Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain. Stroke 1998; 29: 2189-95.
150. Neumann-Haefelin T, Kastrup A, de Crespigny A, et al. Serial MRI after transient focal cerebral ischemia in rats: dynamics of tissue injury, blood-brain barrier damage, and edema formation. Stroke 2000; 31: 1965-72; discussion 1972-3.
151. Kastrup A, Engelhorn T, Beaulieu C, de Crespigny A, Moseley ME. Dynamics of cerebral injury, perfusion, and blood-brain barrier changes after temporary and permanent middle cerebral artery occlusion in the rat. J Neurol Sci 1999; 166: 91-9.
152. Wu XD, Du LN, Wu GC, Cao XD. Effects of electroacupuncture on blood-brain barrier after cerebral ischemia-reperfusion in rat. Acupunct Electrother Res 2001; 26: 1-9.
153. Veltkamp R, Siebing DA, Sun L, et al. Hyperbaric oxygen reduces blood-brain barrier damage and edema after transient focal cerebral ischemia. Stroke 2005; 36: 1679-83.
154. Nagel S, Wagner S, Koziol J, Kluge B, Heiland S. Volumetric evaluation of the ischemic lesion size with serial MRI in a transient MCAO model of the rat: comparison of DWI and T1WI. Brain Res Brain Res Protoc 2004; 12: 172-9.
155. Nagel S, Su Y, Horstmann S, et al. Minocycline and hypothermia for reperfusion injury after focal cerebral ischemia in the rat: effects on BBB breakdown and MMP expression in the acute and subacute phase. Brain Res 2008; 1188: 198-206.
156. Lin TN, Sun SW, Cheung WM, Li F, Chang C. Dynamic changes in cerebral blood flow and angiogenesis after transient focal cerebral ischemia in rats. Evaluation with serial magnetic resonance imaging. Stroke 2002; 33: 2985-91.
157. Lin CY, Chang C, Cheung WM, et al. Dynamic changes in vascular permeability, cerebral blood volume, vascular density, and size after transient focal cerebral ischemia in rats: evaluation with contrast-enhanced magnetic resonance imaging. J Cereb Blood Flow Metab 2008; 28: 1491-501.
158. Strbian D, Durukan A, Pitkonen M, et al. The blood-brain barrier is continuously open for several weeks following transient focal cerebral ischemia. Neuroscience 2008; 153: 175-81.
159. Abo-Ramadan U, Durukan A, Pitkonen M, et al. Post-ischemic leakiness of the blood-brain barrier: a quantitative and systematic assessment by Patlak plots. Exp Neurol 2009; 219: 328-33.
160. Durukan A, Marinkovic I, Strbian D, et al. Post-ischemic bloodbrain barrier leakage in rats: one-week follow-up by MRI. Brain Res 2009; 1280: 158-65.
161. Barr TL, Latour LL, Lee KY, et al. Blood-brain barrier disruption in humans is independently associated with increased matrix metalloproteinase-9. Stroke 2010; 41: e123-8.
162. Pillai DR, Dittmar MS, Baldaranov D, et al. Cerebral ischemiareperfusion injury in rats--a 3 T MRI study on biphasic blood-brain barrier opening and the dynamics of edema formation. J Cereb Blood Flow Metab 2009; 29: 1846-55.
163. Kastrup A, Groschel K, Ringer TM, et al. Early disruption of the blood-brain barrier after thrombolytic therapy predicts hemorrhage in patients with acute stroke. Stroke 2008; 39: 2385-7.
164. Jiang Q, Ewing JR, Ding GL, et al. Quantitative evaluation of BBB permeability after embolic stroke in rat using MRI. J Cereb Blood Flow Metab 2005; 25: 583-92.
165. Henning EC, Latour LL, Warach S. Verification of enhancement of the CSF space, not parenchyma, in acute stroke patients with early blood-brain barrier disruption. J Cereb Blood Flow Metab 2008; 28: 882-6.
166. Rosenberg GA. Neurological diseases in relation to the blood-brain barrier. J Cereb Blood Flow Metab 2012; 32: 1139-51.
167. Asahi M, Asahi K, Jung JC, del Zoppo GJ, Fini ME, Lo EH. Role for matrix metalloproteinase 9 after focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94. J Cereb Blood Flow Metab 2000; 20: 1681-9.
168. Asahi M, Wang X, Mori T, et al. Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of bloodbrain barrier and white matter components after cerebral ischemia. J Neurosci 2001; 21: 7724-32.
169. Magnoni S, Baker A, Thomson S, et al. Neuroprotective effect of adenoviral-mediated gene transfer of TIMP-1 and-2 in ischemic brain injury. Gene Ther 2007; 14: 621-5.
170. Pfefferkorn T, Rosenberg GA. Closure of the blood-brain barrier by matrix metalloproteinase inhibition reduces rtPA-mediated mortality in cerebral ischemia with delayed reperfusion. Stroke 2003; 34: 2025-30.
171. Romanic AM, White RF, Arleth AJ, Ohlstein EH, Barone FC. Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size. Stroke 1998; 29: 1020-30.
172. Dong X, Song YN, Liu WG, Guo XL. Mmp-9, a potential target for cerebral ischemic treatment. Curr Neuropharmacol 2009; 7: 269-75.
173. Ennis SR, Ren XD, Betz AL. Mechanisms of sodium transport at the blood-brain barrier studied with in situ perfusion of rat brain. J Neurochem 1996; 66: 756-63.
174. Lam TI, Wise PM, O'Donnell ME. Cerebral microvascular endothelial cell Na/H exchange: evidence for the presence of NHE1 and NHE2 isoforms and regulation by arginine vasopressin. Am J Physiol Cell Physiol 2009; 297: C278-89.
175. Spatz M, Kawai N, Merkel N, Bembry J, McCarron RM. Functional properties of cultured endothelial cells derived from large microvessels of human brain. Am J Physiol 1997; 272: C231-9.
176. O'Donnell ME. [3H]bumetanide binding in vascular endothelial cells. Quantitation of Na-K-Cl cotransporters. J Biol Chem 1989; 264: 20326-30.
177. O'Donnell ME, Martinez A, Sun D. Endothelial Na-K-Cl cotransport regulation by tonicity and hormones: phosphorylation of cotransport protein. Am J Physiol 1995; 269: C1513-23.
178. Lo WD, Betz AL, Schielke GP, Hoff JT. Transport of sodium from blood to brain in ischemic brain edema. Stroke 1987; 18: 150-7.
179. Betz AL, Ennis SR, Schielke GP. Blood-brain barrier sodium transport limits development of brain edema during partial ischemia in gerbils. Stroke 1989; 20: 1253-9.
180. Betz AL, Iannotti F, Hoff JT. Brain edema: a classification based on blood-brain barrier integrity. Cerebrovasc Brain Metab Rev 1989; 1: 133-54.
181. Betz AL, Coester HC. Effect of steroids on edema and sodium uptake of the brain during focal ischemia in rats. Stroke 1990; 21: 1199-204.
182. Betz AL, Ennis SR, Schielke GP, Hoff JT. Blood-to-brain sodium transport in ischemic brain edema. Adv Neurol 1990; 52: 73-80.
183. Schielke GP, Moises HC, Betz AL. Blood to brain sodium transport and interstitial fluid potassium concentration during early focal ischemia in the rat. J Cereb Blood Flow Metab 1991; 11: 466-71.
184. Betz AL, Keep RF, Beer ME, Ren XD. Blood-brain barrier permeability and brain concentration of sodium, potassium, and chloride during focal ischemia. J Cereb Blood Flow Metab 1994; 14: 29-37.
185. Russell JM. Sodium-potassium-chloride cotransport. Physiol Rev 2000; 80: 211-76.
186. Kahle KT, Staley KJ, Nahed BV, et al. Roles of the cation-chloride cotransporters in neurological disease. Nat Clin Pract Neurol 2008; 4: 490-503.
187. O'Donnell ME, Tran L, Lam TI, Liu XB, Anderson SE. Bumetanide inhibition of the blood-brain barrier Na-K-Cl cotransporter reduces edema formation in the rat middle cerebral artery occlusion model of stroke. J Cereb Blood Flow Metab 2004; 24: 1046-56.
188. O'Donnell ME, Lam TI, Tran L, Anderson SE. The role of the blood-brain barrier Na-K-2Cl cotransporter in stroke. Adv Exp Med Biol 2004; 559: 67-75.
189. Chen H, Luo J, Kintner DB, Shull GE, Sun D. Na(+)-dependent chloride transporter (NKCC1)-null mice exhibit less gray and white matter damage after focal cerebral ischemia. J cerebral blood flow and metabolism: official J the International Society of Cerebral Blood Flow and Metabolism 2005; 25: 54-66.
190. Yan Y, Dempsey RJ, Sun D. Na+-K+-Cl-cotransporter in rat focal cerebral ischemia. J Cereb Blood Flow Metab 2001; 21: 711-21.
191. Yan Y, Dempsey RJ, Flemmer A, Forbush B, Sun D. Inhibition of Na(+)-K(+)-Cl(-) cotransporter during focal cerebral ischemia decreases edema and neuronal damage. Brain Res 2003; 961: 22-31.
192. Luo J, Wang Y, Chen H, et al. A concerted role of Na+-K+-Clcotransporter and Na+/Ca2+ exchanger in ischemic damage. J Cereb Blood Flow Metab 2008; 28: 737-46.
193. Abbruscato TJ, Lopez SP, Mark KS, Hawkins BT, Davis TP. Nicotine and cotinine modulate cerebral microvascular permeability and protein expression of ZO-1 through nicotinic acetylcholine receptors expressed on brain endothelial cells. J Pharm Sci 2002; 91: 2525-38.
194. Kawai N, Yamamoto T, Yamamoto H, McCarron RM, Spatz M. Endothelin 1 stimulates Na+, K(+)-ATPase and Na(+)-K(+)-Clcotransport through ETA receptors and protein kinase C-dependent pathway in cerebral capillary endothelium. J Neurochem 1995; 65: 1588-96.
195. Hansson E, Blomstrand F, Khatibi S, Olsson T, Ronnback L. Glutamate induced astroglial swelling--methods and mechanisms. Acta Neurochir Suppl 1997; 70: 148-51.
196. Su G, Haworth RA, Dempsey RJ, Sun D. Regulation of Na(+)-K(+)-Cl(-) cotransporter in primary astrocytes by dibutyryl cAMP and high [K(+)](o). Am J Physiol Cell Physiol 2000; 279: C1710-21.
197. Su G, Kintner DB, Flagella M, Shull GE, Sun D. Astrocytes from Na(+)-K(+)-Cl(-) cotransporter-null mice exhibit absence of swelling and decrease in EAA release. Am J Physiol Cell Physiol 2002; 282: C1147-60.
198. Su G, Kintner DB, Sun D. Contribution of Na(+)-K(+)-Cl(-) cotransporter to high-[K(+)](o)-induced swelling and EAA release in astrocytes. Am J Physiol Cell Physiol 2002; 282: C1136-46.
199. Beck J, Lenart B, Kintner DB, Sun D. Na-K-Cl cotransporter contributes to glutamate-mediated excitotoxicity. J Neurosci 2003; 23: 5061-8.
200. O'Donnell ME. Endothelial cell sodium-potassium-chloride cotransport. Evidence of regulation by Ca2+ and protein kinase C. J Biol Chem 1991; 266: 11559-66.
201. Wallace BK, Foroutan S, O'Donnell ME. Ischemia-induced stimulation of Na-K-Cl cotransport in cerebral microvascular endothelial cells involves AMP kinase. Am J Physiol Cell Physiol 2011; 301: C316-26.
202. Migliati ER, Amiry-Moghaddam M, Froehner SC, Adams ME, Ottersen OP, Bhardwaj A. Na(+)-K (+)-2Cl (-) cotransport inhibitor attenuates cerebral edema following experimental stroke via the perivascular pool of aquaporin-4. Neurocrit Care 2010; 13: 123-31.
203. Park SL, Lee DH, Yoo SE, Jung YS. The effect of Na(+)/H(+) exchanger-1 inhibition by sabiporide on blood-brain barrier dysfunction after ischemia/hypoxia in vivo and in vitro. Brain Res 2010; 1366: 189-96.
204. Seino S. ATP-sensitive potassium channels: a model of heteromultimeric potassium channel/receptor assemblies. Annu Rev Physiol 1999; 61: 337-62.
205. Chen M, Dong Y, Simard JM. Functional coupling between sulfonylurea receptor type 1 and a nonselective cation channel in reactive astrocytes from adult rat brain. J Neurosci 2003; 23: 8568-77.
206. Simard JM, Chen M, Tarasov KV, et al. Newly expressed SUR1-regulated NC(Ca-ATP) channel mediates cerebral edema after ischemic stroke. Nat Med 2006; 12: 433-40.
207. Simard JM, Yurovsky V, Tsymbalyuk N, Melnichenko L, Ivanova S, Gerzanich V. Protective effect of delayed treatment with lowdose glibenclamide in three models of ischemic stroke. Stroke 2009; 40: 604-9.
208. Boron WF. Regulation of intracellular pH. Adv Physiol Educ 2004; 28: 160-79.
209. Mahnensmith RL, Aronson PS. The plasma membrane sodiumhydrogen exchanger and its role in physiological and pathophysiological processes. Circ Res 1985; 56: 773-88.
210. Pedersen SF, O'Donnell ME, Anderson SE, Cala PM. Physiology and pathophysiology of Na+/H+ exchange and Na+-K+-2Clcotransport in the heart, brain, and blood. Am J Physiol Regul Integr Comp Physiol 2006; 291: R1-25.
211. Chesler M. Regulation and modulation of pH in the brain. Physiol Rev 2003; 83: 1183-221.
212. Nakamura N, Tanaka S, Teko Y, Mitsui K, Kanazawa H. Four Na+/H+ exchanger isoforms are distributed to Golgi and post-Golgi compartments and are involved in organelle pH regulation. J Biol Chem 2005; 280: 1561-72.
213. Orlowski J, Kandasamy RA, Shull GE. Molecular cloning of putative members of the Na/H exchanger gene family. cDNA cloning, deduced amino acid sequence, and mRNA tissue expression of the rat Na/H exchanger NHE-1 and two structurally related proteins. J Biol Chem 1992; 267: 9331-9.
214. Szabo EZ, Numata M, Shull GE, Orlowski J. Kinetic and pharmacological properties of human brain Na(+)/H(+) exchanger isoform 5 stably expressed in Chinese hamster ovary cells. J Biol Chem 2000; 275: 6302-7.
215. Noel J, Roux D, Pouyssegur J. Differential localization of Na+/H+ exchanger isoforms (NHE1 and NHE3) in polarized epithelial cell lines. J Cell Sci 1996; 109 (Pt 5): 929-39.
216. Wang XF, Yu MK, Lam SY, et al. Expression, immunolocalization, and functional activity of Na+/H+ exchanger isoforms in mouse endometrial epithelium. Biol Reprod 2003; 68: 302-8.
217. Hsu P, Haffner J, Albuquerque ML, Leffler CW. pHi in piglet cerebral microvascular endothelial cells: recovery from an acid load. Proc Soc Exp Biol Med 1996; 212: 256-62.
218. Taylor CJ, Nicola PA, Wang S, Barrand MA, Hladky SB. Transporters involved in regulation of intracellular pH in primary cultured rat brain endothelial cells. J Physiol 2006; 576: 769-85.
219. Sipos H, Torocsik B, Tretter L, Adam-Vizi V. Impaired regulation of pH homeostasis by oxidative stress in rat brain capillary endothelial cells. Cell Mol Neurobiol 2005; 25: 141-51.
220. Kitayama J, Kitazono T, Yao H, et al. Inhibition of Na+/H+ exchanger reduces infarct volume of focal cerebral ischemia in rats. Brain Res 2001; 922: 223-8.
221. Lee BK, Lee DH, Park S, et al. Effects of KR-33028, a novel Na+/H+ exchanger-1 inhibitor, on glutamate-induced neuronal cell death and ischemia-induced cerebral infarct. Brain Res 2009; 1248: 22-30.
222. Park HS, Lee BK, Park S, et al. Effects of sabiporide, a specific Na+/H+ exchanger inhibitor, on neuronal cell death and brain ischemia. Brain Res 2005; 1061: 67-71.
223. Luo J, Chen H, Kintner DB, Shull GE, Sun D. Decreased neuronal death in Na+/H+ exchanger isoform 1-null mice after in vitro and in vivo ischemia. J Neurosci 2005; 25: 11256-68.
224. Kintner DB, Su G, Lenart B, et al. Increased tolerance to oxygen and glucose deprivation in astrocytes from Na(+)/H(+) exchanger isoform 1 null mice. Am J Physiol Cell Physiol 2004; 287: C12-21.
225. Horikawa N, Nishioka M, Itoh N, Kuribayashi Y, Matsui K, Ohashi N. The Na(+)/H(+) exchanger SM-20220 attenuates ischemic injury in in vitro and in vivo models. Pharmacology 2001; 63: 76-81.
226. Horikawa N, Kuribayashi Y, Matsui K, Ohashi N. Relationship between the neuroprotective effect of Na+/H+ exchanger inhibitor SM-20220 and the timing of its administration in a transient middle cerebral artery occlusion model of rats. Biol Pharm Bull 2001; 24: 767-71.
227. Hakamata Y, Ito U, Kuroiwa T, Hanyu S, Ohashi N, Nakano I. Combined therapy utilizing a novel Na+/H+ exchange inhibitor (SM-20220) and THAM for ischemic brain edema. Acta Neurochir Suppl 2000; 76: 165-9.
228. Kuribayashi Y, Horikawa N, Itoh N, Kitano M, Ohashi N. Delayed treatment of Na+/H+ exchange inhibitor SM-20220 reduces infarct size in both transient and permanent middle cerebral artery occlusion in rats. Int J Tissue React 1999; 21: 29-33.
229. Gobbi P, Castaldo P, Minelli A, et al. Mitochondrial localization of Na+/Ca2+ exchangers NCX1-3 in neurons and astrocytes of adult rat brain in situ. Pharmacol Res 2007; 56: 556-65.
230. Minelli A, Castaldo P, Gobbi P, Salucci S, Magi S, Amoroso S. Cellular and subcellular localization of Na+-Ca2+ exchanger protein isoforms, NCX1, NCX2, and NCX3 in cerebral cortex and hippocampus of adult rat. Cell Calcium 2007; 41: 221-34.
231. Yamaji R, Fujita K, Takahashi S, et al. Hypoxia up-regulates glyceraldehyde-3-phosphate dehydrogenase in mouse brain capillary endothelial cells: involvement of Na+/Ca2+ exchanger. Biochim Biophys Acta 2003; 1593: 269-76.
232. Domotor E, Abbott NJ, Adam-Vizi V. Na+-Ca2+ exchange and its implications for calcium homeostasis in primary cultured rat brain microvascular endothelial cells. J Physiol 1999; 515 (Pt 1): 147-55.
233. Philipson KD, Nicoll DA. Sodium-calcium exchange: a molecular perspective. Annu Rev Physiol 2000; 62: 111-33.
234. Blaustein MP, Lederer WJ. Sodium/calcium exchange: its physiological implications. Physiol Rev 1999; 79: 763-854.
235. Kiedrowski L. NCX and NCKX operation in ischemic neurons. Ann N Y Acad Sci 2007; 1099: 383-95.
236. Matsuda T, Arakawa N, Takuma K, et al. SEA0400, a novel and selective inhibitor of the Na+-Ca2+ exchanger, attenuates reperfusion injury in the in vitro and in vivo cerebral ischemic models. J Pharmacol Exp Ther 2001; 298: 249-56.
237. Pignataro G, Tortiglione A, Scorziello A, et al. Evidence for a protective role played by the Na+/Ca2+ exchanger in cerebral ischemia induced by middle cerebral artery occlusion in male rats. Neuropharmacology 2004; 46: 439-48.
238. Pignataro G, Gala R, Cuomo O, et al. Two sodium/calcium exchanger gene products, NCX1 and NCX3, play a major role in the development of permanent focal cerebral ischemia. Stroke 2004; 35: 2566-70.